Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

CoreDx™ Pulmonary Mini-Forceps

K-Number: K183085 · 2019-03-08

Decision Date2019-03-08
Product CodeEOQ
Advisory CommitteeEN
DecisionSubstantially Equivalent

Device Summary

CoreDx™ Pulmonary Mini-Forceps is a medical device manufactured by Boston Scientific Corporation. It received FDA 510(k) clearance on 2019-03-08 under approval number K183085. The device is classified under product code EOQ. It was reviewed by the EN advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the CoreDx™ Pulmonary Mini-Forceps?

CoreDx™ Pulmonary Mini-Forceps is a medical device that received FDA 510(k) clearance on 2019-03-08. It is manufactured by Boston Scientific Corporation. The 510(k) number is K183085.

When was CoreDx™ Pulmonary Mini-Forceps approved by the FDA?

CoreDx™ Pulmonary Mini-Forceps received FDA 510(k) clearance on 2019-03-08, under approval number K183085.

What company makes CoreDx™ Pulmonary Mini-Forceps?

CoreDx™ Pulmonary Mini-Forceps is manufactured by Boston Scientific Corporation.

What is the FDA product code for CoreDx™ Pulmonary Mini-Forceps?

The FDA product code for CoreDx™ Pulmonary Mini-Forceps is EOQ.

Related Clinical Trials

Other Devices by Boston Scientific Corporation

View all 176 devices →

Related Devices (Code: EOQ)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.